Accuracy and precision of calibrated arterial pulse contour analysis in patients with subarachnoid hemorrhage requiring high-dose vasopressor therapy: a prospective observational clinical trial.
BACKGROUND
Calibrated arterial pulse contour analysis has become an established method for the continuous monitoring of cardiac output (PCCO). However, data on its validity in hemodynamically instable patients beyond the setting of cardiac surgery are scarce. We performed the present study to assess the validity and precision of PCCO-measurements using the PiCCO™-device compared to transpulmonary thermodilution derived cardiac output (TPCO) as the reference technique in neurosurgical patients requiring high-dose vasopressor-therapy.


METHODS
A total of 20 patients (16 females and 4 males) were included in this prospective observational clinical trial. All of them suffered from subarachnoid hemorrhage (Hunt&Hess grade I-V) due to rupture of a cerebral arterial aneurysm and underwent high-dose vasopressor therapy for the prevention/treatment of delayed cerebral ischemia (DCI). Simultaneous CO measurements by bolus TPCO and PCCO were obtained at baseline as well as 2 h, 6 h, 12 h, 24 h, 48 h and 72 h after inclusion.


RESULTS
PCCO- and TPCO-measurements were obtained at baseline as well as 2 h, 6 h, 12 h, 24 h, 48 h and 72 h after inclusion. Patients received vasoactive support with (mean ± standard deviation, SD) 0.57 ± 0.49 μg · kg-1 · min-1 norepinephrine resulting in a mean arterial pressure of 103 ± 13 mmHg and a systemic vascular resistance of 943 ± 248 dyn · s · cm-5. 136 CO-data pairs were analyzed. TPCO ranged from 5.2 to 14.3 l · min-1 (mean ± SD 8.5 ± 2.0 l · min-1) and PCCO ranged from 5.0 to 14.4 l · min-1 (mean ± SD 8.6 ± 2.0 l · min-1). Bias and limits of agreement (1.96 SD of the bias) were -0.03 ± 0.82 l · min-1 and 1.62 l · min-1, resulting in an overall percentage error of 18.8%. The precision of PCCO-measurements was 17.8%. Insufficient trending ability was indicated by concordance rates of 74% (exclusion zone of 15% (1.29 l · min-1)) and 67% (without exclusion zone), as well as by polar plot analysis.


CONCLUSIONS
In neurosurgical patients requiring extensive vasoactive support, CO values obtained by calibrated PCCO showed clinically and statistically acceptable agreement with TPCO-measurements, but the results from concordance and polar plot analysis indicate an unreliable trending ability.
Sebastian M
SM
Metzelder
Mark
M
Coburn
Christian
C
Stoppe
Michael
M
Fries
Tim-Philipp
TP
Simon
Marcus H T
MH
Reinges
Anke
A
Höllig
Rolf
R
Rossaint
Gernot
G
Marx
Steffen
S
Rex
D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000465:Algorithms; D002138:Calibration; D002302:Cardiac Output / Q000187:drug effects; D002986:Clinical Trials as Topic; D008991:Monitoring, Physiologic / Q000379:methods; D019635:Neurosurgical Procedures; D009638:Norepinephrine / Q000494:pharmacology / Q000627:therapeutic use; D011446:Prospective Studies; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy / Q000503:physiopathology; D013815:Thermodilution / Q000379:methods; D014655:Vascular Resistance; D014662:Vasoconstrictor Agents / Q000494:pharmacology / Q000627:therapeutic use
D009638:Norepinephrine; D014662:Vasoconstrictor Agents